Will Conmed Beat Estimates Again in Its Next Earnings Report?
CNMD Stock | USD 55.81 2.74 5.16% |
About 67 percent of all CONMED's shareholders are curious in acquiring. The analysis of overall sentiment of trading CONMED stock suggests that quite a large number of investors are confidant at this time. The current market sentiment, together with CONMED's historical and current headlines, can help investors time the market. In addition, many technical investors use CONMED stock news signals to limit their universe of possible portfolio assets.
Conmed has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read at zacks.com
![]() |
CONMED Current Investor Sentiment
Comfort Level 67
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use CONMED's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward CONMED.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
CONMED Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards CONMED can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
CONMED Historical Investor Sentiment
Investor biases related to CONMED's public news can be used to forecast risks associated with an investment in CONMED. The trend in average sentiment can be used to explain how an investor holding CONMED can time the market purely based on public headlines and social activities around CONMED. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
CONMED's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for CONMED and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average CONMED news discussions. The higher the estimate score, the more favorable the investor's outlook on CONMED.
CONMED Maximum Pain Price Across November 21st 2025 Option Contracts
CONMED's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of CONMED close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of CONMED's options.
CONMED Fundamental Analysis
We analyze CONMED's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CONMED using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CONMED based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
CONMED is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
CONMED Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CONMED stock to make a market-neutral strategy. Peer analysis of CONMED could also be used in its relative valuation, which is a method of valuing CONMED by comparing valuation metrics with similar companies.
Peers
CONMED Related Equities
IART | Integra LifeSciences | 8.63 | ||||
ICUI | ICU Medical | 5.28 | ||||
BRKR | Bruker | 5.15 | ||||
GKOS | Glaukos Corp | 4.86 | ||||
HAE | Haemonetics | 4.43 | ||||
MMSI | Merit Medical | 3.26 | ||||
OFIX | Orthofix Medical | 0.14 |
Complementary Tools for CONMED Stock analysis
When running CONMED's price analysis, check to measure CONMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CONMED is operating at the current time. Most of CONMED's value examination focuses on studying past and present price action to predict the probability of CONMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CONMED's price. Additionally, you may evaluate how the addition of CONMED to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |